Orsiro
Stent with Hybrid Drug-Eluting Coating **w
Available in France
BIOTRONIK is releasing the Orsiro, the world’s first
Hybrid Drug-Eluting stent, in the French market. The device features a passive proBIO
Coating that isolates the stent’s metal from the vessel walls, and an active BIOlute biocompatible
Coating that releases a limus to prevent reste**sis.
The combination
Coating sits over the company’s PRO-Kinetic Energy
Stent architecture which BIOTRONIK touts as having thin struts and excellent deliverability.
“We are happy to an**unce that the
Orsiro Hybrid DES, one of three
Stent systems in the BIOTRONIK Masterpieces portfolio along
with the PRO-Kinetic Energy bare metal
Stent and the PK Papyrus covered stent, will **w be
Available to yet a**ther patient population that needs it,” Dr. Alexander Uhl, Vice President of Marketing, BIOTRONIK Vascular Intervention, said in a statement. “Physicians rely on top performing tools for each and every procedure. We see the launch of
Orsiro in
France as a crucial step towards giving an even greater number of physicians worldwide the chance to work
with a tool that we consider a Masterpiece.”
Product page:
Orsiro Hybrid Drug Eluting Stent…
Results of the BIOSCIENCE trial comparing
Orsiro with Xience Prime
Stent in
Lancet:
Revisiting the BIOSCIENCE of drug-eluting stent tech**logy…
Press release:
BIOTRONIK to Offer New Treatment Options in France with Release of Orsiro Drug-Eluting Stent…
